Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · IEX Real-Time Price · USD
6.39
0.00 (0.00%)
Jul 22, 2024, 11:30 AM EDT - Market open
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 29 employees as of December 31, 2023. The number of employees decreased by 7 or -19.44% compared to the previous year.
Employees
29
Change (1Y)
-7
Growth (1Y)
-19.44%
Revenue / Employee
$1,550,069
Profits / Employee
$129,310
Market Cap
172.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 1,024 |
OrganiGram Holdings | 984 |
Metagenomi | 236 |
Puma Biotechnology | 185 |
Rigel Pharmaceuticals | 147 |
MediWound | 100 |
Acumen Pharmaceuticals | 52 |
Candel Therapeutics | 42 |
FENC News
- 21 days ago - Fennec Pharmaceuticals Announces Management Change - GlobeNewsWire
- 26 days ago - Fennec Announces Results of Annual Meeting - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024 - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand - GlobeNewsWire
- 5 months ago - Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results - GlobeNewsWire